Skip to main content
رجوع
ANAB logo

AnaptysBio, Inc.

جودة البيانات: 100%
ANAB
NASDAQ Healthcare Biotechnology
KWD 63.02
▲ KWD 0.30 (0.48%)
القيمة السوقية: 1.81B
نطاق اليوم
KWD 60.92 KWD 63.99
نطاق 52 أسبوعًا
KWD 15.40 KWD 68.39
حجم التداول
224,165
متوسط 50 يوم / 200 يوم
KWD 53.61 / KWD 36.18
الإغلاق السابق
KWD 62.72

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -136.9 0.3
P/B 48.7 2.9
ROE % -24.5 3.7
Net Margin % -5.6 3.8
Rev Growth 5Y % 38.8 10.0
D/E 0.4 0.2

السعر المستهدف للمحللين

Hold
KWD 73.710 +17.0%
Low: KWD 50.000 High: KWD 140.000
ربحية السهم المستقبلية
-KWD 3.944
الإيرادات المقدّرة
110 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 4.063
KWD 1.263 – KWD 8.335
490 M 6
FY2029 KWD 0.198
KWD 0.062 – KWD 0.407
320 M 6
FY2028 -KWD 0.343
-KWD 2.486 – KWD 1.735
270 M 8

النقاط الرئيسية

Revenue grew 38.82% annually over 5 years — strong growth
Debt/Equity of 0.38 — conservative balance sheet
Generating 19.61M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 118.19%
Capital efficient — spends only 0.04% of revenue on capex
ROIC of 69.99% — excellent capital efficiency

النمو

Revenue Growth (5Y)
38.82%
Revenue (1Y)157.01%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-24.49%
ROIC69.99%
Net Margin-5.64%
Op. Margin20.42%

الأمان

Debt / Equity
0.38
Current Ratio9.07
Interest Coverage0.60

التقييم

P/E Ratio
-136.92
P/B Ratio48.69
EV/EBITDA33.15
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 157.01% Revenue Growth (3Y) 269.78%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 38.82% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 234.60M Net Income (TTM) -13.23M
ROE -24.49% ROA -3.63%
Gross Margin 98.97% Operating Margin 20.42%
Net Margin -5.64% Free Cash Flow (TTM) 19.61M
ROIC 69.99% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.38 Current Ratio 9.07
Interest Coverage 0.60 Dividend Yield 0.00%
Valuation
P/E Ratio -136.92 P/B Ratio 48.69
P/S Ratio 7.72 PEG Ratio 1.12
EV/EBITDA 33.15 Dividend Yield 0.00%
Market Cap 1.81B Enterprise Value 1.59B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 234.60M 91.28M 17.16M 10.29M 63.18M
Net Income -13.23M -145.23M -163.62M -128.72M -57.80M
EPS (Diluted) -0.46 -5.12 -6.08 -4.57 -2.11
Gross Profit 232.18M -72.56M -115.13M -78.51M -35.32M
Operating Income 47.90M -114.95M -164.41M -115.15M -56.81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 364.40M 483.83M 452.39M 610.38M 643.07M
Total Liabilities 327.19M 412.97M 364.29M 348.28M 286.64M
Shareholders' Equity 37.21M 70.87M 88.10M 262.10M 356.43M
Total Debt 14.11M 369.46M 17.81M 19.45M 20.96M
Cash & Equivalents 238.20M 123.08M 35.97M 71.31M 495.73M
Current Assets 350.25M 431.88M 406.84M 447.21M 553.88M
Current Liabilities 38.63M 45.43M 37.44M 26.05M 16.10M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#8 of 146
76

النشاط الأخير

دخل Full Throttle
Mar 24, 2026